Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest Periods

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of this study is to determine the pharmacokinetics of BTDS following same-site patch reapplication after rest intervals.

Key facts

Study ID

NCT01259102

Run by

Purdue Pharma LP

People needed

70

Starts

2000-11-01

Expected to finish

2001-03-01

Last updated by the study team

2012-09-03

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

Where it is running

• The Ohio State University Department of Pharmacology — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.